Monoclonal antibodies (mAbs) have become the most growth-accelerated segment of the biopharmaceutical industry, with advanced molecular engineering and antibody humanization making it possible to ...

MINNEAPOLIS, July 28, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and PROGEN today announced the launch of the Simple Plex™ Adeno-Associated Virus (AAV2) viral titer assay for AAV2 ...

The use of biologic-based therapeutics has revolutionized our ability to treat complex diseases such as cancer- and autoimmune-related disorders. Biologic-based therapeutics are known to generate anti ...

In a recent study posted to the medRxiv* preprint server, the researchers investigated the effect of binding antibodies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron ...

Immunotherapy is a rapidly growing field with multiple therapeutic modalities including, but not limited to, antibody drug conjugates, bispecific antibodies, and CAR-(chimeric antigen receptor) ...

The advent of gene therapy has unlocked new possibilities for treating diseases previously regarded as intractable. However, producing adeno-associated virus (AAV)-mediated gene therapy products ...

Simple Plex AAV assays combine industry leading AAV antibody reagents from PROGEN with convenience and simplicity of the fully automated Ella platform. MINNEAPOLIS, Oct. 11, 2022 /PRNewswire/ -- ...

Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly gaining traction as a strategy for the treatment of genetic diseases. The ...

MOG-IgG positivity is rare in MS patients, complicating diagnosis and treatment, especially in Asian populations with lower ...